Tower Bridge Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$534K Sell
12,500
-750
-6% -$40.7K 0.05% 165
2026
Q1
$831K Buy
13,250
+2,150
+19% +$172K 0.08% 134
2025
Q4
$1.06M Buy
11,100
+8,150
+276% +$799K 0.11% 108
2025
Q3
$288K Buy
+2,950
New +$306K 0.03% 166

Other funds holding BSX

Tower Bridge Advisors's BSX Position: Q2 2026 in Review

Tower Bridge Advisors reduced its Boston Scientific (BSX) stake by 5.7% in Q2 2026, selling an estimated $40.7K and leaving 12,500 shares worth $534K. The position accounts for 0.05% of the portfolio, ranked #165.

Tower Bridge Advisors first reported a position in BSX in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.06M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Tower Bridge Advisors held 12,500 shares of Boston Scientific worth $534K as of Q2 2026.
  • Tower Bridge Advisors sold 750 Boston Scientific shares in Q2 2026, an estimated $40.7K.
  • Boston Scientific made up 0.05% of Tower Bridge Advisors's portfolio in Q2 2026, its #165 holding.
  • Tower Bridge Advisors first reported a position in Boston Scientific in Q3 2025 and has held it in 4 quarters since.
  • Tower Bridge Advisors's Boston Scientific position peaked at $1.06M in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Tower Bridge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.